221 related articles for article (PubMed ID: 30901717)
1. Current status of nanoscale drug delivery systems for colorectal cancer liver metastasis.
Hong Y; Rao Y
Biomed Pharmacother; 2019 Jun; 114():108764. PubMed ID: 30901717
[TBL] [Abstract][Full Text] [Related]
2. Targeting High Expressed α
Shao S; Zhu Y; Meng T; Liu Y; Hong Y; Yuan M; Yuan H; Hu F
Mol Pharm; 2018 Apr; 15(4):1653-1663. PubMed ID: 29533631
[TBL] [Abstract][Full Text] [Related]
3. Anti-metastatic treatment in colorectal cancer: targeting signaling pathways.
Lemos C; Sack U; Schmid F; Juneja M; Stein U
Curr Pharm Des; 2013; 19(5):841-63. PubMed ID: 22973955
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
Martin RC; Scoggins CR; Schreeder M; Rilling WS; Laing CJ; Tatum CM; Kelly LR; Garcia-Monaco RD; Sharma VR; Crocenzi TS; Strasberg SM
Cancer; 2015 Oct; 121(20):3649-58. PubMed ID: 26149602
[TBL] [Abstract][Full Text] [Related]
5. Implanted hepatic arterial infusion pumps.
Callahan MK; Kemeny NE
Cancer J; 2010; 16(2):142-9. PubMed ID: 20404611
[TBL] [Abstract][Full Text] [Related]
6. Liver cancer stem cells as an important target in liver cancer therapies.
Zou GM
Anticancer Agents Med Chem; 2010 Feb; 10(2):172-5. PubMed ID: 20298161
[TBL] [Abstract][Full Text] [Related]
7. Targeting the extracellular signature of metastatic colorectal cancers.
Marchiò S; Arap W; Pasqualini R
Expert Opin Ther Targets; 2009 Mar; 13(3):363-79. PubMed ID: 19236157
[TBL] [Abstract][Full Text] [Related]
8. Treatment options for metastatic colorectal cancer in patients with liver dysfunction due to malignancy.
Faugeras L; Dili A; Druez A; Krug B; Decoster C; D'Hondt L
Crit Rev Oncol Hematol; 2017 Jul; 115():59-66. PubMed ID: 28602170
[TBL] [Abstract][Full Text] [Related]
9. Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency.
Sugimoto M; Yasuda H; Koda K; Yamazaki M; Tezuka T; Takenoue T; Kosugi C; Higuchi R; Yamamoto S; Watayo Y; Yagawa Y; Suzuki M
Hepatogastroenterology; 2007 Sep; 54(78):1684-8. PubMed ID: 18019695
[TBL] [Abstract][Full Text] [Related]
10. Netrin-1 as a potential target for metastatic cancer: focus on colorectal cancer.
Ko SY; Blatch GL; Dass CR
Cancer Metastasis Rev; 2014 Mar; 33(1):101-13. PubMed ID: 24338005
[TBL] [Abstract][Full Text] [Related]
11. Liver-directed therapies in colorectal cancer.
Alsina J; Choti MA
Semin Oncol; 2011 Aug; 38(4):561-7. PubMed ID: 21810515
[TBL] [Abstract][Full Text] [Related]
12. [Role of hepatic arterial infusion chemotherapy in the treatment of colorectal cancer liver metastases].
Liu M; Xing BC
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(12):881-3. PubMed ID: 23863668
[No Abstract] [Full Text] [Related]
13. Antiangiogenic Therapy in Colorectal Cancer.
Mody K; Baldeo C; Bekaii-Saab T
Cancer J; 2018; 24(4):165-170. PubMed ID: 30119079
[TBL] [Abstract][Full Text] [Related]
14. Modeling of liver metastatic disease with applied drug therapy.
Filipovic N; Djukic T; Saveljic I; Milenkovic P; Jovicic G; Djuric M
Comput Methods Programs Biomed; 2014 Jul; 115(3):162-70. PubMed ID: 24831076
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
Bhutiani N; Akinwande O; Martin RC
World J Surg; 2016 May; 40(5):1178-90. PubMed ID: 26711640
[TBL] [Abstract][Full Text] [Related]
16. Weighted gene co-expression network analysis of colorectal cancer liver metastasis genome sequencing data and screening of anti-metastasis drugs.
Gao B; Shao Q; Choudhry H; Marcus V; Dong K; Ragoussis J; Gao ZH
Int J Oncol; 2016 Sep; 49(3):1108-18. PubMed ID: 27571956
[TBL] [Abstract][Full Text] [Related]
17. Pilot phase I/II personalized therapy trial for metastatic colorectal cancer: evaluating the feasibility of protein pathway activation mapping for stratifying patients to therapy with imatinib and panitumumab.
Pierobon M; Silvestri A; Spira A; Reeder A; Pin E; Banks S; Parasido E; Edmiston K; Liotta L; Petricoin E
J Proteome Res; 2014 Jun; 13(6):2846-55. PubMed ID: 24787230
[TBL] [Abstract][Full Text] [Related]
18. Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study.
Martin RC; Joshi J; Robbins K; Tomalty D; Bosnjakovik P; Derner M; Padr R; Rocek M; Scupchenko A; Tatum C
Ann Surg Oncol; 2011 Jan; 18(1):192-8. PubMed ID: 20740319
[TBL] [Abstract][Full Text] [Related]
19. [Intra-arterial chemotherapy, using the hepatic artery, in metastases of colorectal carcinoma].
Hidalgo OF; Gil AC; Campbell W; Hidalgo V; Santos M; Henríquez I; Martín S; Sureda M; Antón LM
Rev Med Univ Navarra; 1987; 31(3):169-76. PubMed ID: 3333892
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer.
Browning DD
Expert Opin Ther Targets; 2008 Mar; 12(3):367-76. PubMed ID: 18269345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
